StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Hualan Biological Bacterin Inc.
Shenzhen Stock Exchange:301207.SZ
Sector
Industries
Location
Market Cap
USD 1.42 B
Share Price
USD 2.35
Avg Daily Volume
2,280,983
Change (1 day)
-0.62%
Change (1 year)
1.43%
Change (YTD)
-2.14%
Hualan Biological Bacterin Inc. Free Cash Flow for the year ending December 31, 2024: USD 57.04 M
Hualan Biological Bacterin Inc. Free Cash Flow is USD 57.04 M for the year ending December 31, 2024, a -50.94% change year over year. Free cash flow is the amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.
-
Hualan Biological Bacterin Inc. Free Cash Flow for the year ending December 31, 2023 was USD 116.26 M, a 309.30% change year over year.
-
Hualan Biological Bacterin Inc. Free Cash Flow for the year ending December 31, 2022 was USD 28.40 M, a -370.46% change year over year.
-
Hualan Biological Bacterin Inc. Free Cash Flow for the year ending December 31, 2021 was USD -10.50 M, a -142.47% change year over year.
-
Hualan Biological Bacterin Inc. Free Cash Flow for the year ending December 31, 2020 was USD 24.73 M, a 31.32% change year over year.
Competitors
Sanofi
USD 96.95
SAN.PA
-1.69
-1.71%
Moderna, Inc.
USD 30.50
MRNA
+0.21
0.71%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
USD 8.49
603392.SS
-0.11
-1.24%
Swedish Orphan Biovitrum AB (publ)
USD 29.72
SOBI.ST
-0.14
-0.46%
Ionis Pharmaceuticals, Inc.
USD 43.24
IONS
-0.35
-0.80%
Chongqing Zhifei Biological Products Co., Ltd.
USD 2.73
300122.SZ
-0.03
-1.23%
Shanghai Junshi Biosciences Co., Ltd.
USD 3.22
1877.HK
+0.17
5.42%
Vaxcyte, Inc.
USD 33.25
PCVX
-0.02
-0.06%
Rhythm Pharmaceuticals, Inc.
USD 65.77
RYTM
-1.15
-1.72%
Hualan Biological Engineering Inc.
USD 2.21
002007.SZ
-0.01
-0.29%
Apogee Therapeutics, Inc.
USD 47.80
APGE
+3.48
7.85%
Apellis Pharmaceuticals, Inc.
USD 18.26
APLS
+0.44
2.47%
Ligand Pharmaceuticals Incorporated
USD 114.58
LGND
+0.92
0.81%
NewAmsterdam Pharma Company N.V.
USD 19.85
NAMS
+0.89
4.69%
Bavarian Nordic A/S
USD 26.66
BAVA.CO
-0.01
-0.05%
Adaptive Biotechnologies Corporation
USD 11.80
ADPT
+0.32
2.79%
Immunocore Holdings plc
USD 33.02
IMCR
+0.27
0.82%
ARS Pharmaceuticals, Inc.
USD 16.52
SPRY
-0.23
-1.37%
AbbVie Inc.
USD 189.28
ABBV
-1.47
-0.77%
Novo Nordisk A/S
USD 68.84
NOVO-B.CO
-0.79
-1.13%
Key Data
| Date | Free Cash Flow | Operating Cash Flow | Capital Expenditure | Net Cash Used For Investing Activities |
|---|
Competitors
Sanofi
USD 96.95
SAN.PA
-1.69
-1.71%
Moderna, Inc.
USD 30.50
MRNA
+0.21
0.71%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
USD 8.49
603392.SS
-0.11
-1.24%
Swedish Orphan Biovitrum AB (publ)
USD 29.72
SOBI.ST
-0.14
-0.46%
Ionis Pharmaceuticals, Inc.
USD 43.24
IONS
-0.35
-0.80%
Chongqing Zhifei Biological Products Co., Ltd.
USD 2.73
300122.SZ
-0.03
-1.23%
Shanghai Junshi Biosciences Co., Ltd.
USD 3.22
1877.HK
+0.17
5.42%
Vaxcyte, Inc.
USD 33.25
PCVX
-0.02
-0.06%
Rhythm Pharmaceuticals, Inc.
USD 65.77
RYTM
-1.15
-1.72%
Hualan Biological Engineering Inc.
USD 2.21
002007.SZ
-0.01
-0.29%
Apogee Therapeutics, Inc.
USD 47.80
APGE
+3.48
7.85%
Apellis Pharmaceuticals, Inc.
USD 18.26
APLS
+0.44
2.47%
Ligand Pharmaceuticals Incorporated
USD 114.58
LGND
+0.92
0.81%
NewAmsterdam Pharma Company N.V.
USD 19.85
NAMS
+0.89
4.69%
Bavarian Nordic A/S
USD 26.66
BAVA.CO
-0.01
-0.05%
Adaptive Biotechnologies Corporation
USD 11.80
ADPT
+0.32
2.79%
Immunocore Holdings plc
USD 33.02
IMCR
+0.27
0.82%
ARS Pharmaceuticals, Inc.
USD 16.52
SPRY
-0.23
-1.37%
AbbVie Inc.
USD 189.28
ABBV
-1.47
-0.77%
Novo Nordisk A/S
USD 68.84
NOVO-B.CO
-0.79
-1.13%